A class action lawsuit was filed on behalf of patients with Ranitidine allergy who received the wrong drug when their prescriptions were sent to pharmacies in Canada. Zantac is a different brand, but it often has similar ingredients as Ranitidine.
The “zantac lawsuit update 2021” is a law suit that was filed against Ranitidine and Zantac. The case name is “Do You Qualify: Canada”.
Who Is Affected by Zantac Carcinogens and Cancer Risks?
- Concerns that Zantac and other ranitidine medicines may contain potentially hazardous amounts of a recognized carcinogen have prompted a recall.
- You may have a legal claim if you were diagnosed with cancer after using ranitidine medicines like Zantac.
Concerns that Zantac and other ranitidine products had high amounts of an impurity designated as a potential human carcinogen prompted a worldwide ranitidine recall in 2019.
Ranitidine is a commonly used stomach acid blocker for the treatment of heartburn. Zantac is a well-known brand name for ranitidine, which is available over-the-counter and via prescription.
Many furious customers have taken legal action against the medication makers in reaction to the worldwide recall, accusing them of continuing to sell the pills while knowing they presented a possible Zantac cancer risk.
Potential litigants from Ontario and British Columbia are being sought by lawyers.
If you (or a loved one) used Zantac or any other ranitidine drug and were diagnosed with one of the following malignancies, you may be eligible to join our lawsuit investigation:
- Bladder cancer is a kind of cancer that affects the bladder
- Breast cancer is a kind of cancer that affects
- Cancer of the stomach
To see whether you’re eligible, fill out the form below.
If you meet the requirements, a lawyer will contact you for a no-cost case assessment.
What Was the Reason for Zantac’s Recall?
In October 2019, Health Canada issued a recall for ranitidine after tests revealed it had excessive amounts of N-nitrosodimethylamine (NDMA), a potential human carcinogen. Because of the NDMA contamination, a worldwide ranitidine recall was initiated.
As a consequence of the Zantac recall, heartburn relief medicines such as Pepcid (famotidine) were in limited supply in Canada, as Zantac consumers sought alternate treatments for their symptoms. Due to the voluntary nature of the ranitidine recall of NDMA-contaminated heartburn medicines in the United States, there were no shortages.
According to Health Canada’s recall updates website, customers impacted by the Zantac recall should contact their doctor or pharmacist to learn about non-ranitidine heartburn treatment options. Consumers were urged not to stop taking the drug until they discovered another treatment option since the consequences of not treating their illness were potentially greater than the risk of NDMA exposure.
Products made by the following companies were involved in the Health Canada ranitidine recall:
- Apotex Inc. is a pharmaceutical company based in the United States.
- Pharmacal Dominion
- Riva Laboratoire Inc.
- Pharmascience Inc. is a company that specializes in pharmaceutical research and
- Pro Doc Limited Edition
- Ranbaxy Pharmaceuticals Canada Inc. is a pharmaceutical company based in Canada.
- Sandoz Canada is a pharmaceutical company.
- Sanis Health Inc. is a company that specializes in health care.
- Sanofi Consumer Health Inc. is a subsidiary of Sanofi.
- Sivem Pharmaceuticals ULC is a pharmaceutical company based in the United Kingdom.
- Teva Canada Limited is a company based in Canada.
- Vita Health Products Inc. is a company that manufactures health products.
Health Canada stated in July 2020 that businesses wanting to market ranitidine products must implement stronger safety procedures and submit test results to the agency.
Is Zantac a Cancer Causer?
The NDMA contaminant discovered in certain ranitidine formulations is the source of the Zantac cancer risk. Based on animal research, the European Medicines Agency has concluded that NDMA is a potential human carcinogen.
NDMA is an environmental pollutant that may be found in water, vegetables, meat, and dairy products, according to the US Food and Drug Administration.
Individuals who are exposed to high amounts of NDMA over a long period of time may be at an increased risk of Zantac cancer if they use medications that were contaminated with NDMA during the manufacturing process.
The Therapeutic Goods Administration, Australia’s regulatory body, claims that NDMA contamination poses a minimal risk of Zantac cancer.
The TGA said, “However, such contamination is deemed inappropriate for a medication.” “The real health hazards vary from person to person and are dependent on the dosage. The hazards of using ranitidine for a short period of time are anticipated to be very minimal.”
What Are the Other Side Effects of Ranitidine?
According to WebMD, the following ranitidine side effects are uncommon and mild:
- Rash on the Skin
- Cramps in the stomach
Zantac usage may cause severe ranitidine side effects including altered liver function, hepatitis, jaundice, depression, interstitial nephritis, pancreatic inflammation, fever, hallucinations, or pneumonia in rare cases.
Have there been any Zantac cancer lawsuits filed in Canada?
In Canada, many Zantac cancer cases have already been filed. Long-term exposure to NDMA, according to a Vancouver man who has used ranitidine medicines on and off for a number of years, has caused him emotional anguish as well as an elevated chance of getting cancer.
In April 2020, two plaintiffs filed a Zantac case in the Ontario Superior Court of Justice, alleging that Zantac’s manufacturers knew or should have known that the ranitidine drug was dangerous for ingestion yet continued to sell it.
Following the ranitidine recall in 2019, a Quebec citizen filed a Zantac cancer lawsuit on behalf of a class of Canadian people who bought the allegedly tainted medication.
Free Case Evaluation for Zantac and Ranitidine Drug Recalls in Canada
For a free case assessment, please fill out the form below. If you meet the criteria, a lawyer will contact you at no cost to explore the specifics of your possible case.
ADVERTISING FOR ATTORNEYS
The choice of a lawyer is a significant one that should not be made simply on the basis of advertising.
Jeffrey Preszler, who is responsible for the content of this page, may be reached at:
Preszler Injury Lawyers is a law firm that specializes in personal injury cases.
THIS IS A PAID ATTORNEY ADVERTISEMENT, AND THE PARTICIPATING ATTORNEY(S) ARE INCLUDED BECAUSE THEY PAY AN ADVERTISING FEE. Top Class Actions is neither a law practice, a lawyer referral service, or a legal services package with pre-paid legal services. We do not support or suggest any of the network’s third-party claims processing companies, lawyers, or law firms. We make no representations about the qualifications, competence, or credentials of any participating lawyer or processing organization, and we have made no judgments about them. There is no guarantee that the legal services or claims processing to be conducted will be of higher quality than legal services or claims processing provided by other attorneys or claims processing groups. This material is not intended to be legal advice. Any information you provide to Top Class Actions does not establish an attorney-client relationship, and it may or may not be protected by attorney-client privilege. Your information will instead be submitted to an attorney or claims processing company for a private assessment and possible representation. Top Class Actions or the participating lawyers may be compelled by a court of law to provide your information in certain legal circumstances, therefore you should not use this website to submit time-sensitive, private, or privileged material. All of the photographs on this page are of models, not clients.
The American Bar Association is a proud member of Top Class Actions.
GETTING LEGAL INFORMATION IS NOT THE SAME AS GETTING LEGAL ADVICE.
This site is intended to assist people securely deal with their own legal requirements by providing information on the law and lawsuits. Legal information is not the same as legal advice, which is the application of the law to a particular situation. Although we go to great efforts to ensure that our material is accurate and helpful, if you want professional assurance that our information, and your interpretation of it, is suitable to your specific circumstances, we suggest that you contact a lawyer. All posts or writings on TopClassActions.com by staff or others should be regarded as personal opinion only, not legal advice. Legal Statement for Top Class Actions
During the years 2008 to 2021, Top Class Actions® LLC is a law firm that specializes in class actions.
Several trademarks are owned by their respective owners.
Please keep in mind that Top Class Actions is neither a legal firm or a settlement administrator. Top Class Actions is a legal news website that covers class action litigation, settlements, drug harm claims, and product liability lawsuits. Top Class Actions does not handle claims and cannot provide you with information about the status of any class action settlement claim. If you have any concerns concerning your claim status, claim form, or when funds are anticipated to be sent out, you must contact the settlement administrator or your attorney.
The “is ranitidine back on the market” is a question that comes up often. The answer is yes, but there are some conditions to this.
Frequently Asked Questions
Who qualifies for Zantac lawsuit?
A: The lawsuit is against the manufacturers of Zantac, not people who have purchased it.
What is the average payout for Zantac lawsuit?
A: The average payout for this lawsuit is $45,000.
How can I prove I took Zantac?
A: You should contact your doctor and see what they have to say about proofing that you took the medication.
- when will the zantac lawsuit be settled
- zantac lawsuit settlement amounts
- how to qualify for zantac lawsuit
- zantac lawsuit update 2022
- best attorney for zantac lawsuit